Invex Therapeutics Ltd
  • Home
  • About Us
    • Company Overview
    • Directors & Management
    • Corporate Governance
  • Development Strategy
  • Investors
    • ASX Announcements
    • Company Reports
    • Presentations
    • Analyst Reports
    • Top Shareholders
    • Share Registry
    • Publications
    • Fact Sheets
  • Media
    • Articles
  • Careers
    • Current Openings
  • Contact Us
Select Page

Small Caps – Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

by Invex Therapeutics | Jan 27, 2021 | Articles-General, media

Click to view the full...

COVID-19 Impact on IIH – J Neurol article by Prof Alex Sinclair

by Invex Therapeutics | Jan 11, 2021 | Articles-General, media

View...

JAMA Ophthalmology Publication – Alex Sinclair

by Invex Therapeutics | Oct 23, 2020 | Articles-General, media

View...

Nature – Volume 586 – Alexandra Sinclair: Easing the Pressure

by Invex Therapeutics | Oct 15, 2020 | Articles-General, media

View...

Emerging Stocks Down Under

by Invex Therapeutics | Sep 22, 2020 | Articles-General, media

View...

Momentum builds for small cap biotechs

by Invex Therapeutics | Jun 15, 2020 | Articles-General, media

View...
« Older Entries

Recent Posts

  • Small Caps – Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder
  • COVID-19 Impact on IIH – J Neurol article by Prof Alex Sinclair
  • JAMA Ophthalmology Publication – Alex Sinclair
  • Nature – Volume 586 – Alexandra Sinclair: Easing the Pressure
  • Emerging Stocks Down Under

Recent Comments

    Archives

    • January 2021
    • October 2020
    • September 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • July 2019
    • June 2019

    Categories

    • Articles-General
    • Inactive Openings
    • media

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org